Previous Article | Next Article 
Journal of Clinical Microbiology, April 2001, p. 1540-1548, Vol. 39, No. 4
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.4.1540-1548.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Identification and Characterization of Phage Variants of a
Strain of Epidemic Methicillin-Resistant Staphylococcus
aureus (EMRSA-15)
G. L.
O'Neill,1,*
S.
Murchan,1
A.
Gil-Setas,2 and
H. M.
Aucken1
Laboratory of Hospital Infection, Central
Public Health Laboratory, London, NW9 5HT, United
Kingdom,1 and Microbiologia, Virgin
del Campino Hospital, Pamplona, Spain2
Received 18 September 2000/Returned for modification 11 November
2000/Accepted 11 January 2001
 |
ABSTRACT |
EMRSA-15 is one of the most important strains of epidemic
methicillin-resistant Staphylococcus aureus (EMRSA) found
in the United Kingdom. It was originally characterized by weak lysis with phage 75 and production of enterotoxin C but not urease. Two
variant strains of EMRSA-15 which show a broader phage pattern than the
progenitor strain have emerged. A total of 153 recent clinical isolates
representing classical EMRSA-15 (55 isolates) or these phage variants
(98 isolates) were compared by SmaI macrorestriction profiles in pulsed-field gel electrophoresis (PFGE) as well as by
urease and enterotoxin C production. Eight of the 98 isolates were
shown to be other unrelated strains by both PFGE and their production
of urease, a misidentification rate of 8% by phage typing. Seventy-one
EMRSA-15 isolates were enterotoxin C negative, and the majority of
these were sensitive to phage 81. Examination of PFGE profiles and
Southern blotting studies suggest that the enterotoxin C gene locus is
encoded on a potentially mobile DNA segment of ca. 15 kb. After
elimination of the eight non-EMRSA-15 isolates, the remaining 145 were
characterized by PFGE, yielding 22 profiles. All profiles were within
five band differences of at least one other profile. Classical EMRSA-15
isolates showed nine PFGE profiles, with the majority of isolates
(68%) in profile B1. Six of these nine PFGE profiles were unique to
the classical EMRSA-15 isolates. Among the phage variants of EMRSA-15,
16 profiles were seen, but the majority of isolates (83%) fell into 1 of 4 profiles (B2, B3, B4, and B7) which correlated well with phage patterns. The most divergent PFGE profiles among the EMRSA-15 isolates
had as many as 12 band differences from one another, suggesting that in
examining isolates belonging to such a temporally and geographically
disseminated epidemic strain, the range of PFGE profiles must be
regarded as a continuum and analyzed by relating the profiles back to
the most common or progenitor profile.
 |
INTRODUCTION |
Staphylococcus aureus is
the leading cause of surgical wound infections and the second most
frequent cause of bacteremia in the hospital setting (7).
Methicillin-resistant S. aureus (MRSA) first appeared in the
early 1960s but virtually disappeared during the 1970s in the United
Kingdom. It reappeared in the early 1980s (18), and over
the last two decades, strains with resistance to an extended range of
antibiotics have emerged to pose a major threat to public health. MRSA
isolates may comprise as much as 45% of the total number of
S. aureus isolated from patients with bacteremia
(2). Thousands of isolates are sent each year to the
S. aureus Reference Service (SaRS) at the Central
Public Health Laboratory (CPHL) for typing; there they are subdivided
primarily on the basis of their susceptibilities to 27 phages
(19, 21). Where additional discrimination between strains
is required, SmaI digests of chromosomal DNA are subjected
to pulsed-field gel electrophoresis (PFGE) (24).
Epidemic strains of MRSA are defined as those which have been
identified in two or more patients in two or more hospitals (13). The first epidemic MRSA (EMRSA) strain, designated
EMRSA-1, was recognized in 1981 (17) and continued to
cause outbreaks in hospitals until the late 1980s. A second EMRSA
strain, EMRSA-2, emerged in the late 1980s (22) and was
followed closely by 12 other EMRSA strains described-during a survey
carried out in 1987 and 1988 (13). EMRSA-15 emerged during
1991 and rapidly displaced most of the other EMRSA strains
(1). It has now spread to, and is endemic in, hundreds of
hospitals across the United Kingdom; it has also recently been
identified as causing outbreaks in Australia, New Zealand, Germany,
Sweden, and Finland. The strain classically is characterized by weak
lysis with phage (
) 75 of the international set, production of
enterotoxin C, and nonproduction of urease (24).
In recent years two "variant" strains of EMRSA-15 have been
recognized by SaRS. They were identified as EMRSA-15 variants despite
producing additional phage reactions, notably with phages 42E, 81, 83C,
and 90, because they were phenotypically similar to classical EMRSA-15
isolates (i.e., in colonial morphology, toxin production, and lack of
urease production) and arose in hospitals with large circulating
EMRSA-15 populations. Subsequent investigation of some of these
isolates by PFGE revealed that they gave SmaI digestion
patterns identical or closely related to those of the classical
EMRSA-15 isolates, and they were coded as phage variants "42E" and
"83C." Subsequently, some of these variants have lost the reaction
with phage 75 which was initially a defining characteristic of
EMRSA-15.
This study was undertaken to determine, firstly, whether all isolates
classified as EMRSA-15 phage variants are genotypically EMRSA-15;
secondly, whether variation in phage pattern is related to variation in
PFGE profile; and finally, whether any other characteristics of the
strain vary with particular changes in phage pattern and/or PFGE profile.
 |
MATERIALS AND METHODS |
Bacterial strains.
In total, 153 clinical isolates of
EMRSA-15 and the EMRSA-15 phage variants "42E" and "83C" were
examined. Isolates were selected for inclusion in the following manner.
Phage typing records of isolates from 1998 were used to identify all 55 hospitals from disparate geographical locations in England, Wales, and
the Republic of Ireland which had sent phage variants of EMRSA-15 to
SaRS. In some hospitals, multiple different phage variants (i.e.,
patterns showing reaction differences from one another) were found, so a single representative of each phage variant pattern was included from
each hospital. In total, 98 isolates representing the phage variants of
EMRSA-15 were selected for further study. In addition, classical
EMRSA-15 isolates (based on a weak reaction with phage 75 only) were
selected as controls from 49 of the 55 hospitals (no classical EMRSA-15
isolates were present in 6 of the hospitals). Upon subsequent
enterotoxin testing, the "classical" isolates from six hospitals
were found to be enterotoxin C negative. Due to this finding, an
additional classical isolate from each of these hospitals, which was
enterotoxin C positive, was included. The EMRSA-15 type strain (NCTC
13142) was included as a control strain for enterotoxin C production,
PFGE, and phage typing. Additional controls were NCTC 8325, ATCC 29213 (susceptibility testing), and the enterotoxin-producing strains NCTC
10652 (enterotoxin A; gene sea), NCTC 10654 (enterotoxin B;
seb), NCTC 10655 (enterotoxin C; sec), NCTC 10656 (enterotoxin D; sed), and NCTC 11963 (toxic shock syndrome
toxin [TSST-1], tst). Isolates were stored on nutrient agar (NA) slopes at room temperature and recovered by subculture on NA
plates followed by overnight incubation at 37°C. All isolates were
maintained on Microbank beads (Prolab, UK) at
70°C.
Phenotypic characterization of strains.
Strains were phage
typed in triplicate using the international phage set (21)
and local experimental phages 88A, 90, 83C, and 932 (19).
Phage typing of the isolates was performed at 100 times the routine
test dilution (100× RTD) because most United Kingdom MRSA isolates are
nontypeable at RTD (23). Isolates were tested for
coagulase, urease production, and antimicrobial susceptibility by
standard methods as previously described (13).
The following agents were tested by the agar dilution method on
Isosensitest agar (Oxoid, Ltd., Basingstoke, United Kingdom) with 2%
horse blood and interpreted using the following resistance breakpoints:
ciprofloxacin, >1 mg/liter; erythromycin,
0.5 mg/liter; fusidic
acid,
1 mg/liter; gentamicin, >1 mg/liter; kanamycin, >4 mg/liter;
neomycin, >4 mg/liter; methicillin,
4 mg/liter; mupirocin,
8
mg/liter; streptomycin, >4 mg/liter; rifampin, >0.12 mg/liter;
teicoplanin,
4 mg/liter; tetracycline,
1 mg/liter; and vancomycin,
4 mg/liter.
mecA PCR.
Isolates which were sensitive to
methicillin were examined for carriage of the mecA gene by
PCR according to the method of Bignardi et al. (6).
Enterotoxin detection.
All isolates were screened for the
presence of enterotoxin genes A through D (sea through
sed) and the TSST-1 gene (tst) by the method of
Johnson et al. (10), but DNA was extracted by boiling in
5% Chelex 100 (Bio-Rad Laboratories, Hercules, Calif.) and lysates
were centrifuged to remove cell debris. The supernatant was transferred
to a fresh tube, and 5 µl was used as a template in the PCRs
(20). Selected isolates were also tested for the production of enterotoxins A through D using a reverse passive latex
agglutination kit (SET-RPLA; Oxoid Ltd.) according to the manufacturer's instructions.
PFGE.
PFGE was performed by the method of Kaufmann
(11). Briefly, DNA was extracted from overnight cultures
grown at 37°C on NA and restriction digested with SmaI
(Boehringer GmbH, Mannheim, Germany) overnight at 30°C according to
the manufacturer's instructions. Digested DNA was electrophoresed in
1.2% agarose gels for 30 h with a ramped pulse time of 1 to
80 s using a CHEF DRII or CHEF Mapper (Bio-Rad Laboratories). DNA
fragments were visualized by staining with 0.5 µg of ethidium
bromide/ml. Gels were photographed under UV illumination, and the data
were saved to a floppy disk prior to analysis. Gel data were analyzed
with GelCompar software (Applied Maths, Kortrijk, Belgium).
Probe generation, Southern blotting, and hybridization.
A
subset of isolates were examined for enterotoxin C gene
(sec) carriage by Southern blotting. A 699-bp biotin-labeled
sec probe was generated by PCR using the following primers:
TGT ATC AGC AAC TAA AGT TAA GTC and AAA GGCAAG CAC CGA
AG. PCR was performed in a total volume of 100 µl containing
2.5 U of Taq polymerase, 200 µM deoxynucleoside
triphosphates, 68 µM biotin-16-dUTP, 2 mM MgCl2, 20 mM
Tris-HCl (pH 8.4), 50 mM KCl, and 5 µl of template DNA (prepared as
described above). Cycling conditions consisted of 1 cycle of
denaturation at 96°C for 2 min followed by 30 cycles of denaturation
at 94°C for 1 min, annealing at 52°C for 1 min, and extension at
72°C for 1 min, with a final extension at 72°C for 5 min. The PCR
product was purified using a QIAquick PCR purification kit (Qiagen
Ltd., Crawley, United Kingdom), and the probe concentration was
estimated spectrophotometrically at 260 nm. DNA fragments from PFGE
gels were transferred to nylon membranes (Hybond N; Amersham, Little
Chalfont, Buckinghamshire, United Kingdom) by vacuum blotting according
to the method of Kaufmann et al. (12) with the following
modifications: the fragmentation solution (0.25 M HCl) was applied for
25 min, the denaturation solution (0.5 M NaOH-1.5 M NaCl) was applied
for 1 h, the neutralization solution (1.5 M NaCl-0.5 M Tris) was
applied for 30 min, and then blotting was undertaken using 20× SSC
(1× SSC is 0.15 M NaCl plus 0.015 M sodium citrate) for 2 h at
5 × 103 Pa. Hybridization was performed by the method
of Kaufmann et al. (12) using the sec probe at
a concentration of 1 µg/ml. Commercially available biotinylated
DNA digested with HindIII at a concentration of 1 µg/ml was used as a probe to detect the
concatamer size standards
on the PFGE gels. Hybridization was detected with the BlueGene
Nonradioactive Detection System (Gibco BRL, Life Technologies, Paisley,
United Kingdom).
 |
RESULTS |
Coagulase production and methicillin resistance.
All isolates
were coagulase positive, and 149 of 153 isolates were resistant to
methicillin. Of the four methicillin-sensitive isolates, one was
positive for the mecA gene by PCR. The other three isolates
were included in the study despite being methicillin sensitive because
their phage patterns were as expected and loss of the mecA
gene upon storage is known to occur (14).
Susceptibility to other antimicrobial agents.
The sensitivity
patterns for the classical and variant EMRSA-15 isolates were similar,
with all isolates susceptible to gentamicin, neomycin, teicoplanin, and
vancomycin and the majority susceptible to fusidic acid, kanamycin,
mupirocin, rifampin, streptomycin, and tetracycline (Table
1). However, almost all classical
EMRSA-15 isolates (94%) were resistant to ciprofloxacin, and the
majority were resistant to erythromycin (80%). Resistance to these two antibiotics was less frequent among the variant isolates (76 and 62%,
respectively).
Phage typing.
All 55 clinical isolates included as classical
EMRSA-15 isolates gave the expected phage reaction of 75wk (coded as
phage pattern 1). Isolates of the variant strains reacted with a
combination of the expected phages: 42E, 75, 81, 83C, and 90 (Table
2). Certain weak reactions were variable
when strains were typed in triplicate, but there was always a core of
conserved reactions for each isolate. Ten major phage patterns could be
delineated. Isolates belonging to phage variant "83C" inevitably
had a strong reaction with this phage and reacted variably with phages
42E, 81, and 90 (coded as phage pattern 2). The phage patterns defined
among this group were 83C/90 (with or without 42E
phage pattern 2a)
and 83C (phage pattern 2b). Isolates belonging to phage variant
"42E" always reacted strongly with phage 42E and reacted variably
with phages 75, 81, 83C, and 90 (coded as phage pattern 3). The phage
patterns defined among this group were 42E/75/81/90 (3a), 42E/81/83C/90 (3b), 42E/75/81/83C/90 (3c), 42E/81/83C (3d), 42E/75/90 (3e), and
42E/75/81/83C (3f). In addition, one isolate gave the phage pattern
42E/79/81(phage pattern 4). Patterns were further subdivided on the
basis of reaction strength (Table 2).
PFGE and urease results.
Initially PFGE data were analyzed by
comparing band differences between PFGE profiles. The data were used to
generate a dendrogram of percent relatedness calculated by the Dice
coefficient and represented by UPGMA (Fig.
1), and five clearly different PFGE "clusters" were identified. The clusters with multiple isolates were coded B (145 isolates) and C (five isolates), and the others with
only a single representative were considered unique. All isolates
within cluster B showed more than 75% relatedness, with only 40%
relatedness to the other four clusters and to NCTC 8325. The other
clusters in turn showed no more than 65% relatedness to each other.
Each of the clusters differed from all other clusters by at least 14 bands. Cluster B accounted for 145 of 153 (95%) isolates, including
all 55 classical EMRSA-15 isolates. All cluster B isolates were urease
negative. In contrast, the cluster C isolates and the three unique
isolates were urease positive. These results suggest that these
isolates had been misclassified by phage typing, i.e., an error rate of
8% for phage identification of EMRSA-15 variants. One of the
methicillin-sensitive isolates belonged to cluster B (giving the
classical phage pattern of 75wk), while the other two had unique PFGE
profiles. PFGE variants occurred within clusters B and C, and these are
described in more detail below. Representative profiles are shown in
Fig. 2.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 1.
Dendrogram of percent relatedness of PFGE profiles from
putative EMRSA-15 isolates calculated using the Dice coefficient and
represented by UPGMA. Band tolerances were set at 1.0%.
|
|

View larger version (72K):
[in this window]
[in a new window]
|
FIG. 2.
SmaI restriction profiles of putative
EMRSA-15 isolates. (Top): PFGE profiles B1 through B16; (bottom) PFGE
profiles B17 through B24 and the non-EMRSA-15 profiles (C1 through C5
and unique profiles). A commercial molecular weight marker consisting
of concatemers of lambda DNA, the EMRSA-15 control strain NCTC 13142, and S. aureus strain NCTC 8325 were included as controls on
all gels.
|
|
Subtyping isolates within the B cluster.
Among the 145 isolates within the EMRSA-15 cluster (B), 22 PFGE profiles, differing
by at least one band, were seen (B1 through 19, B21, B23, and 24). A
band difference matrix was generated using these data (Fig.
3). The EMRSA-15 type strain was
designated B1, as were 36 other classical EMRSA-15 isolates (67% of
classical isolates). The remaining 18 classical EMRSA-15 isolates
produced eight PFGE profiles with 1 to 3 band differences from the
progenitor pattern, B1 (Table 2). One classical EMRSA-15 isolate was
methicillin sensitive, and its profile, B24, differed from B1 by a
single band shift (a ca. 225-kb band was replaced by a ca. 190-kb
band). Variant EMRSA-15 isolates showed 16 different PFGE profiles
including B1, although this profile accounted for only two isolates.
Four profiles, B2, B3, B4, and B7, accounted for 75 isolates (83% of phage variants), with the rest of the profiles represented by 1 or 2 isolates. The four main profiles were associated with phage patterns
2a, 3a, 3b or 3d, and 3c, respectively (Table 2). However, the
correlation between these four phage patterns and PFGE profiles was not
absolute. Four isolates exhibited one of the phage patterns listed
above but produced different PFGE profiles (B8, B14, and B16). Further,
five classical EMRSA-15 isolates had profile B3 and one had profile B7.

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 3.
Band difference matrix of PFGE profiles of EMRSA-15
isolates. Numbers represent the band differences between PFGE profiles
listed on the x and y axes.
|
|
Correlation of phage and PFGE patterns with geographical location
and hospital.
There was no obvious link between
geographical location and the EMRSA-15 phage variants or
PFGE subtypes (data not shown). Hospitals represented by more
than one isolate usually showed multiple PFGE and phage variants, and
there was no correlation between the PFGE profiles of the classical and
variant isolates in the 49 hospitals represented by both.
Enterotoxin gene carriage and production.
Enterotoxin genes
sea through sed and tst were not
detected in isolates from PFGE cluster C or among those with unique
PFGE profiles (i.e., the eight non-EMRSA-15 isolates). All isolates from PFGE cluster B were negative for genes sea, seb, sed,
and tst, although 74 carried the sec gene. These
included all isolates belonging to subtypes B1, B2, B5, B6, B18, and
B23, which were sec positive by PCR and/or Southern
blotting. All isolates belonging to the remaining B subtypes were
negative for sec (by PCR and Southern blotting) and did not
produce enterotoxin C. The sec gene was localized to a ca.
110-kb fragment on PFGE gels (Fig. 4).
Isolates carrying the enterotoxin C gene appeared to have a band
doublet at this position in their PFGE profiles, whereas isolates
without the gene appeared to have a single band at this position and an
extra band at ca. 95 kb (Fig. 5). There
was a clear association between absence of the enterotoxin C gene and sensitivity to
81 (Table 3).

View larger version (91K):
[in this window]
[in a new window]
|
FIG. 4.
Hybridization of a probe for sec to
SmaI restriction profiles of enterotoxin C-positive and
-negative EMRSA-15 isolates. Size standards were visualized by probing
with biotin-labeled digested with HindIII. Isolates
belonging to PFGE profiles B1 and B2 were sec positive by
PCR, and those belonging to profiles B3 and B4 were negative. EMRSA-16
was included as a negative control.
|
|

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 5.
Overlaid densitometric curves of the PFGE profiles of
variants B1 and B3 illustrating the difference in peak heights of the
band at 110 kb in the profile. Band sizes quoted are approximate.
|
|
 |
DISCUSSION |
This study was undertaken to extend our knowledge of the
characteristics of one of the two major EMRSA strains in the United Kingdom. Previously, EMRSA-15 had been defined by a weak reaction with
75 of the international set, enterotoxin C production, and nonproduction of urease. Over the past decade, phage variants of this
strain have arisen across the United Kingdom, but given that this
strain has been circulating for at least 9 years, it is not suprising
that some genetic change has taken place. A similar broadening of the
phage typing pattern was observed with the epidemic penicillinase-producing 80/81 strain of the 1950s (21).
This highly transmissable and virulent strain was shown to have spread across, and persisted in, several continents. The original phage pattern of 80/81 widened to 52/52A/80/81 over time and in different geographic locations. A defective prophage was responsible for the
resistance of the original 80/81 strain to
52 and
52A, and replacement of this prophage by other phages resulted in the typing pattern difference (25). Presumably, a similar mechanism
is responsible for the alteration of the EMRSA-15 phage pattern, although we have not yet attempted to identify the phages responsible for this.
Identification of EMRSA-15 phage variants.
More than 90% of
isolates classified as phage variants of EMRSA-15 by phage typing were
shown to be bona fide EMRSA-15 by PFGE, validating the usefulness
of this quick and cost-effective method for typing. In addition, the
fact that all the strains misidentified as EMRSA-15 were urease
producers confirms that this simple test would eliminate the majority
of false identifications. Furthermore, the phage patterns of the
variant strains were generally stable and a core of strong reactions
was identified. Although a well-established rule exists for
interpreting phage patterns at RTD (two or more strong reaction
differences define unrelated strains), this has not yet been validated
at 100× RTD, and in any case it was intended for use only with
geographically and temporally related isolates. This study suggests
that these reaction difference rules may need to be modified for
strains that require typing at 100× RTD.
Discrimination between EMRSA-15 isolates by PFGE.
The
demonstration of different PFGE profiles among, and unique to, the
classical EMRSA-15 isolates illustrates the role that genetic events
such as point mutations, insertions, and deletions may play in altering
the PFGE patterns of closely related isolates. The profile (B24) of one
classical EMRSA-15 isolate, which was methicillin sensitive, differed
from the progenitor pattern B1 by a single band shift from ca. 225 kb
to ca. 190 kb. The size of the shift in molecular weight equates well
with that published for the mec locus in United Kingdom MRSA
isolates (9) and suggests that it is the loss of this
genetic element which has generated subtype B24 from B1. The
concordance between PFGE profile and phage pattern for variant isolates
is indicative of the link between loss or gain of prophages from the
genome (resulting in widening of the phage typing pattern) and changes
in either SmaI restriction sites or fragment sizes
responsible for the PFGE banding patterns. Interestingly, three PFGE
profiles, B1, B3, and B7, were represented by both variant and
classical isolates. Most B1 isolates were classical EMRSA-15 exhibiting
the 75wk pattern, but two isolates reacted with phages 83C/90 and
42E/75/90 respectively. Conversely, although the majority of B3 and B7
isolates were EMRSA-15 variants, five B3 isolates and one B7 isolate
gave the classical pattern 75wk. These findings suggest that
replacement of prophages by other circulating phages may cause
changes in the PFGE profile which are not reflected by changes
in the phage pattern and vice versa. This is supported by data from
Arbeit (3), who showed that different phages could be
obtained from isolates with identical PFGE patterns and also that the
same phage could insert into different fragments, creating strains
which had the same genetic composition but PFGE patterns which differed
by as many as 4 bands. These findings illustrate that no typing system
is absolute and that sometimes even a simple system such as phage
typing can give as much, if not more, information than a complex
DNA-based typing system such as PFGE.
Criteria for interpretation of PFGE data.
For epidemiological
typing, knowledge of both strain identity and variability within the
strain allows us to make judgments on whether direct cross-infection or
independent acquisition has taken place. However, interpretation of
PFGE data obtained from a widespread strain such as EMRSA-15 can be
problematic with regard to both strain identity and variability.
For local epidemiological studies, criteria of strain relatedness such
as those described by Tenover et al. (
26) with the
modifications of Goering (
8) are often applied. These
criteria
suggest that isolates showing 1 to 3 band differences from the
outbreak (or progenitor) strain are probably related and part
of the
outbreak and that those showing 4 to 6 band differences
may be related.
However, these criteria are validated only for
use within
epidemiologically and temporally defined (<6 months)
outbreaks.
Isolates in this study were chosen from geographically
diverse
locations and were temporally spaced. Despite this, the
majority of
isolates within the B cluster fell within 1 to 3 band
differences from
the progenitor pattern, B1. These findings suggest
that most isolates
belonging to the B cluster differ by one genetic
event from B1 and that
even the most divergent member of the B
cluster, B11, may differ from
B1 by only two genetic events (giving
a 6-band difference in the PFGE
profile). How then, do we distinguish
between cross-infection and
independent acquisition of a strain
such as EMRSA-15 when closely
related PFGE profiles are obtained
from isolates recovered during a
suspected outbreak? A recent
study by MacFarlane et al.
(
16) retrospectively analyzed two
putative outbreaks of
EMRSA-15 within a United Kingdom hospital.
In one outbreak they found
several different PFGE profiles differing
by 1 to 4 bands, whereas in
the second a single PFGE profile was
identified. They suggested that in
a highly clonal organism such
as EMRSA-15, perhaps even single band
differences between isolates
may be of epidemiological significance.
Prospective epidemiological
studies involving hospitals with a large
circulating EMRSA-15
population and known phage and/or PFGE subtypes
may be helpful
in attempting to answer this
question.
Although most PFGE profiles obtained from isolates within the B cluster
were closely related to the progenitor profile B1,
higher numbers of
band differences were seen when the more-divergent
PFGE variant
profiles were compared with each other. For example,
B11 and B18 differ
by 12 bands. Comparing these two profiles in
isolation and interpreting
the results using the Tenover criteria
would lead to their
classification as different strains. Although
two isolates with such
widely differing PFGE profiles are unlikely
to represent an incident of
cross-infection, classifying them
as belonging to different genetic
lineages is erroneous. This
suggests that in dealing with a widely
disseminated strain such
as EMRSA-15, the range of PFGE profiles must
be regarded as a
continuum and cutoff points such as 4 to 6 band
differences (which
are appropriate for isolates from putative
temporally and geographically
related outbreaks) are too stringent for
determining strain identity.
It also emphasizes the importance of
relating profiles back to
the most common (or progenitor) profile for
analysis.
Carriage of the sec gene.
Of particular interest
was the appearance of enterotoxin C-negative variants of EMRSA-15.
These had previously been reported for some isolates with the classical
EMRSA-15 phage pattern (24) but had not been correlated
with a change in PFGE profile. Examination of sec-negative
isolates showed that loss of this gene was associated with a specific
change in PFGE profile, namely, a marked decrease in the intensity of
the ca. 110-kb band hybridizing to the sec gene probe in
sec-positive isolates, concomitant with the appearance of an
extra band at ca. 95 kb. Furthermore, the sec gene probe failed to hybridize with the remaining ca. 110-kb band in the profile
of sec-negative variants. Examination of peak heights in the
densitometric traces of the sec-positive and -negative isolates supports the view that sec-positive isolates are
characterized by a doublet band at ca. 110 kb, whereas in
sec-negative strains only a single band is present (Fig. 5).
These findings suggest that the sec gene is carried on a
piece of DNA of ca. 15 kb, which appears to have been excised from the
genome in sec-negative variants.
It is known that enterotoxin genes are often located on mobile
elements. Enterotoxin A is phage encoded (
5), enterotoxin
D is plasmid borne (
4), and TSST-1 is encoded on a
pathogenicity
island (
15). The relatively small size of
the fragment change
suggests that enterotoxin C is not phage encoded,
since the average
size of the phage genome is ca. 45 to 50 kb. Studies
on the TSST-1
pathogenicity islands SAPI1 and SAPI2 have shown that the
tst gene is carried on a 17-kb segment of DNA that can be
mobilized
by certain phages (
15). It may be, therefore,
that enterotoxin
C is encoded on a similar pathogenicity island, since
the size
of the element appears to be similar and there is a phage
association
in that the majority of the isolates which were
sec negative were
sensitive to

81. Further studies to
test this hypothesis are
under
way.
Overall, this study has shown the usefulness of both phage typing and
PFGE for monitoring the evolution of a prevalent strain
of MRSA within
the United Kingdom and has suggested further avenues
of exploration
concerning transmission of virulence factors within
S. aureus.
 |
ACKNOWLEDGMENTS |
We thank Tyrone Pitt and Barry Cookson for critical comments on
the manuscript and Maria Mena, Mark Ganner, and Marina Warner for
technical assistance.
A. Gil-Setas was supported by a grant from the Spanish Society of
Infectious Diseases and Clinical Microbiology. S. Murchan was funded by
the EU DG-XII HARMONY project and participated in this project to
facilitate method development for HARMONY.
 |
FOOTNOTES |
*
Corresponding author. Present address: Division of
Environmental Health and Risk Management, Public Health Building,
University of Birmingham, Birmingham B15 2TT, United Kingdom. Phone: 44 121 414 7750. Fax: 44 121 414 3078. E-mail:
g.l.oneill{at}bham.ac.uk.
 |
REFERENCES |
| 1.
|
Anonymous.
1992.
Methicillin-resistant Staphylococcus aureus (MRSA).
Communicable Dis. Rep.
2:21.
|
| 2.
|
Anonymous.
1999.
Methicillin resistance in Staphylococcus aureus isolated from blood in England and Wales: 1994 to 1998.
Communicable Dis. Rep.
9:65, 68.
|
| 3.
|
Arbeit, R. D.
1997.
Laboratory procedures for epidemiologic analysis, p. 253-286.
In
K. B. Crossley, and G. L. Archer (ed.), The staphylococci in human disease. Churchill Livingstone, New York, N.Y.
|
| 4.
|
Bayles, K. W., and J. J. Iandolo.
1989.
Genetic and molecular analyses of the gene encoding staphylococcal enterotoxin D.
J. Bacteriol.
171:4799-4806[Abstract/Free Full Text].
|
| 5.
|
Betley, M. J., and J. J. Mekalanos.
1985.
Staphylococcal enterotoxin A is encoded by phage.
Science
229:185-187[Abstract/Free Full Text].
|
| 6.
|
Bignardi, G. E.,
N. Woodford,
A. Chapman,
A. P. Johnson, and D. C. E. Speller.
1996.
Detection of the mecA gene and phenotypic detection of resistance in Staphylococcus aureus isolates with borderline or low-level methicillin resistance.
J. Antimicrob. Chemother.
37:53-63[Abstract/Free Full Text].
|
| 7.
|
Boyce, J. M.
1997.
Epidemiology and prevention of nosocomial infections, p. 309-329.
In
K. B. Crossley, and G. L. Archer (ed.), The staphylococci in human disease. Churchill Livingstone, New York, N.Y.
|
| 8.
|
Goering, R. V.
1998.
The molecular epidemiology of nosocomial infection: an overview of principles, application and interpretation, p. 131-157.
In
S. Specter, et al. (ed.), Rapid detection of infectious agents. Plenum Press, New York, N.Y.
|
| 9.
|
Hiramatsu, K.,
T. Ito, and H. Hanaki.
1999.
Mechanisms of methicillin and vancomycin resistance in Staphylococcus aureus.
Clin. Infect. Dis.
5:221-239.
|
| 10.
|
Johnson, W. M.,
S. D. Tyler,
E. P. Ewan,
F. E. Ashton,
D. R. Pollard, and K. R. Rozee.
1991.
Detection of genes for enterotoxins, exfoliative toxins, and toxic shock syndrome toxin 1 in Staphylococcus aureus by the polymerase chain reaction.
J. Clin. Microbiol.
29:426-430[Abstract/Free Full Text].
|
| 11.
|
Kaufmann, M. E.
1998.
Pulsed-field gel electrophoresis, p. 33-50.
In
N. Woodford, and A. P. Johnson (ed.), Molecular bacteriology: protocols and clinical applications. Humana Press, Totawa, N.J.
|
| 12.
|
Kaufmann, M. E.,
D. G. Pitcher, and T. L. Pitt.
1994.
Ribotyping of the bacterial genome, p. 123-138.
In
H. Chart (ed.), Methods in practical laboratory bacteriology. CRC Press Inc., Boca Raton, Fla.
|
| 13.
|
Kerr, S.,
G. E. Kerr,
C. A. Makintosh, and R. R. Marples.
1990.
A survey of methicillin-resistant Staphylococcus aureus affecting patients in England and Wales.
J. Hosp. Infect.
16:35-48[CrossRef][Medline].
|
| 14.
|
Lacey, R. W., and A. Stokes.
1979.
Studies on recently isolated cultures of methicillin-resistant Staphylococcus aureus.
J. Gen. Microbiol.
114:329-339[Abstract/Free Full Text].
|
| 15.
|
Lindsay, J. A.,
A. Ruzin,
H. F. Ross,
N. Kurepina, and R. P. Novick.
1998.
The gene for toxic shock toxin is carried by a family of mobile pathogenicity islands in Staphylococcus aureus.
Mol. Microbiol.
29:527-543[CrossRef][Medline].
|
| 16.
|
MacFarlane, L.,
J. Walker,
R. Borrow,
B. A. Oppenheim, and A. J. Fox.
1999.
Improved recognition of MRSA case clusters by the application of molecular subtyping using pulsed-field gel electrophoresis.
J. Hosp. Infect.
41:29-37[CrossRef][Medline].
|
| 17.
|
Marples, R. R., and E. M. Cooke.
1985.
Workshop on methicillin-resistant Staphylococcus aureus.
J. Hosp. Infect.
6:342-348[Medline].
|
| 18.
|
Marples, R. R., and S. Reith.
1992.
Methicillin-resistant Staphylococcus aureus in England and Wales.
Communicable Dis. Rep. Rev.
2:R25-R29.
|
| 19.
|
Marples, R. R.,
J. F. Richardson, and M. J. de Saxe.
1986.
Bacteriological characters of strains of Staphylococcus aureus submitted to a reference laboratory related to methicillin resistance.
J. Hyg. Camb.
96:217-223[Medline].
|
| 20.
|
O'Neill, G. L,
F. T. Ogunsola,
J. S. Brazier, and B. I. Duerden.
1996.
Modification of a PCR ribotyping method for application as a routine typing scheme for Clostridium difficile.
Anaerobe
2:205-209.
|
| 21.
|
Parker, M. T.
1983.
The significance of phage-typing patterns in Staphylococcus aureus, p. 33-62.
In
C. S. F. Easmon, and C. Adlam (ed.), Staphylococci and staphylococcal infections. Academic Press Inc., London, England.
|
| 22.
|
Richardson, J. F., and R. R. Marples.
1988.
Another strain of methicillin-resistant Staphylococcus aureus epidemic in London.
Lancet
ii:748.
|
| 23.
|
Richardson, J. F.,
A. H. M. Quoraishi,
B. J. Francis, and R. R. Marples.
1990.
Beta-lactamase-negative, methicillin-resistant Staphylococcus aureus in a newborn nursery: report of an outbreak and laboratory investigations.
J. Hosp. Infect.
16:109-121[CrossRef][Medline].
|
| 24.
|
Richardson, J. F., and S. Reith.
1993.
Characterization of a strain of methicillin-resistant Staphylococcus aureus (EMRSA-15) by conventional and molecular methods.
J. Hosp. Infect.
25:45-52[CrossRef][Medline].
|
| 25.
|
Rountree, P. M., and E. H. Asheshov.
1961.
Further observations on changes in the phage-typing pattern of phage type 80/81 staphylococci.
J. Gen. Microbiol.
26:111-122[Abstract/Free Full Text].
|
| 26.
|
Tenover, F. C.,
R. D. Arbeit,
R. V. Goering,
P. A. Mickelsen,
B. E. Murray,
D. H. Persing, and B. Swaminathan.
1995.
Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial typing.
J. Clin. Microbiol.
33:2233-2239[Medline].
|
Journal of Clinical Microbiology, April 2001, p. 1540-1548, Vol. 39, No. 4
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.4.1540-1548.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Wolter, D. J., Chatterjee, A., Varman, M., Goering, R. V.
(2008). Isolation and Characterization of an Epidemic Methicillin-Resistant Staphylococcus aureus 15 Variant in the Central United States. J. Clin. Microbiol.
46: 3548-3549
[Full Text]
-
Strommenger, B., Braulke, C., Heuck, D., Schmidt, C., Pasemann, B., Nubel, U., Witte, W.
(2008). spa Typing of Staphylococcus aureus as a Frontline Tool in Epidemiological Typing. J. Clin. Microbiol.
46: 574-581
[Abstract]
[Full Text]
-
Ghebremedhin, B., Konig, W., Witte, W., Hardy, K. J., Hawkey, P. M., Konig, B.
(2007). Subtyping of ST22-MRSA-IV (Barnim epidemic MRSA strain) at a university clinic in Germany from 2002 to 2005. J Med Microbiol
56: 365-375
[Abstract]
[Full Text]
-
Hsu, L.-Y., Loomba-Chlebicka, N., Koh, Y.-L., Tan, T.-Y., Krishnan, P., Lin, R. T.-P., Tee, N. W.-S., Fisher, D. A., Koh, T.-H.
(2007). Evolving EMRSA-15 epidemic in Singapore hospitals. J Med Microbiol
56: 376-379
[Abstract]
[Full Text]
-
Gomes, A. R., Westh, H., de Lencastre, H.
(2006). Origins and Evolution of Methicillin-Resistant Staphylococcus aureus Clonal Lineages.. Antimicrob. Agents Chemother.
50: 3237-3244
[Abstract]
[Full Text]
-
Strommenger, B., Kehrenberg, C., Kettlitz, C., Cuny, C., Verspohl, J., Witte, W., Schwarz, S.
(2006). Molecular characterization of methicillin-resistant Staphylococcus aureus strains from pet animals and their relationship to human isolates. J Antimicrob Chemother
57: 461-465
[Abstract]
[Full Text]
-
Sola, C., Cortes, P., Saka, H. A., Cordoba MRSA Collaborative Study Group, , Vindel, A., Bocco, J. L.
(2006). Evolution and Molecular Characterization of Methicillin-Resistant Staphylococcus aureus Epidemic and Sporadic Clones in Cordoba, Argentina. J. Clin. Microbiol.
44: 192-200
[Abstract]
[Full Text]
-
Murchan, S., Aucken, H. M., O'Neill, G. L., Ganner, M., Cookson, B. D.
(2004). Emergence, Spread, and Characterization of Phage Variants of Epidemic Methicillin-Resistant Staphylococcus aureus 16 in England and Wales. J. Clin. Microbiol.
42: 5154-5160
[Abstract]
[Full Text]
-
Perez-Roth, E., Lorenzo-Diaz, F., Batista, N., Moreno, A., Mendez-Alvarez, S.
(2004). Tracking Methicillin-Resistant Staphylococcus aureus Clones during a 5-Year Period (1998 to 2002) in a Spanish Hospital. J. Clin. Microbiol.
42: 4649-4656
[Abstract]
[Full Text]
-
O'Brien, F. G., Lim, T. T., Chong, F. N., Coombs, G. W., Enright, M. C., Robinson, D. A., Monk, A., Said-Salim, B., Kreiswirth, B. N., Grubb, W. B.
(2004). Diversity among Community Isolates of Methicillin-Resistant Staphylococcus aureus in Australia. J. Clin. Microbiol.
42: 3185-3190
[Abstract]
[Full Text]
-
Melter, O., Aires de Sousa, M., Urbaskova, P., Jakubu, V., Zemlickova, H., de Lencastre, H.
(2003). Update on the Major Clonal Types of Methicillin-Resistant Staphylococcus aureus in the Czech Republic. J. Clin. Microbiol.
41: 4998-5005
[Abstract]
[Full Text]
-
Gustafson, J. E., O'Brien, F. G., Coombs, G. W., Malkowski, M. J., Grubb, W. B., Pfeltz, R. F., Wilkinson, B. J.
(2003). Alterations in phage-typing patterns in vancomycin-intermediate Staphylococcus aureus. J Med Microbiol
52: 711-714
[Abstract]
[Full Text]
-
Watson, J., Givney, R., Beard-Pegler, M., Rose, B., Merlino, J., Vickery, A., Gottlieb, T., Bradbury, R., Harbour, C.
(2003). Comparative Analysis of Multidrug-Resistant, Non-Multidrug-Resistant, and Archaic Methicillin-Resistant Staphylococcus aureus Isolates from Central Sydney, Australia. J. Clin. Microbiol.
41: 867-872
[Abstract]
[Full Text]
-
Huygens, F., Nimmo, G. R., Schooneveldt, J., Munckhof, W. J., Giffard, P. M.
(2002). Genotyping of Methicillin-Resistant Staphylococcus aureus by Assaying for the Presence of Variable Elements Associated with mecA. J. Clin. Microbiol.
40: 3093-3097
[Abstract]
[Full Text]
-
MOORE, P.C. L., LINDSAY, J.A.
(2002). Molecular characterisation of the dominant UK methicillin-resistant Staphylococcus aureus strains, EMRSA-15 and EMRSA-16. J Med Microbiol
51: 516-521
[Abstract]
[Full Text]
-
Aucken, H. M., Westwell, K.
(2002). Reaction Difference Rule for Phage Typing of Staphylococcus aureus at 100 Times the Routine Test Dilution. J. Clin. Microbiol.
40: 292-293
[Abstract]
[Full Text]